- €7.91bn
- €11.70bn
- €7.86bn
- 29
- 85
- 87
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 14,042 | 11,713 | 12,998 | 7,321 | 7,861 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12,977 | 10,187 | 11,901 | 6,228 | 6,504 |
Operating Profit | 1,065 | 1,526 | 1,097 | 1,093 | 1,357 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1,433 | 1,533 | 1,231 | 1,489 | 1,428 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,178 | 1,300 | 1,016 | 1,284 | 1,177 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 979 | 1,141 | 845 | 1,097 | 953 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 979 | 1,141 | 845 | 1,097 | 953 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.6 | 6.89 | 5.16 | 6.82 | 5.79 |
Dividends per Share |